News
29 Jun 2014
alopecia universalis arthritis baldness hair research hair treatments tofacitinib yale

Arthritis treatment, tofacitinib, cured a Alopecia Universalis patient during a study at Yale.

BOSTON (CBS) – Scientists at Yale may have discovered quite the off-label use for an FDA-approved arthritis drug.During a trial which stretched for eight months, a 25-year-old man with almost no hair on his body grew a full head following…
read more